共 59 条
- [1] Carratala J(2002)The antibiotic-lock technique for therapy of ‘highly needed’ infected catheters Clin Microbiol Infect 8 282-289
- [2] Ceri H(1999)The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms J Clin Microbiol 37 1771-1776
- [3] Olson ME(2003)Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for staphylococcus epidermidis central venous catheter-related biofilm infections Antimicrob Agents Chemother 47 3145-3148
- [4] Stremick C(2007)Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm Antimicrob Agents Chemother 51 1656-1660
- [5] Read RR(2006)Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study J Antimicrob Chemother 57 1172-1180
- [6] Morck D(2001)Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique Antimicrob Agents Chemother 45 1565-1567
- [7] Buret A(2005)Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy J Antimicrob Chemother 56 951-953
- [8] Curtin J(1999)Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports) Antimicrob Agents Chemother 43 2074-2076
- [9] Cormican M(1993)Successful treatment of haemodialysis catheter-related sepsis without catheter removal Nephrol Dial Transplant 8 231-234
- [10] Fleming G(2002)Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis J Antimicrob Chemother 50 615-617